|
|
|
|||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
| (Return to page 14) | |||||||||||||||||||||||||||||||||||||
|
|
Bone Disorders The incidence of avascular necrosis (AVN) is increasing in HIV-infected patients. (1) Although corticosteroid use is significantly associated with AVN, its pathogenesis is likely to be multifactorial. (2) Treatment advocate, Nairy Ghazourian notes that certain preclinical signs and symptoms signal the presence of AVN. An on-line treatment information newsletter from Seattle Treatment Education Project notes what HIV-positive people can do now to lessen the risk of AVN. The use of shark cartilage to treat this condition is questionable. Sources
2. Glesby MJ, Hoover DR, Vaamonde CM. Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study. J Infect Dis 2001;184(4):519-23. Caffeine appears to have a role in bone loss based on recent study results. Reports from a cross-sectional and a 3-year longitudinal study of bone mineral density (BMD) in 489 postmenopausal women found that those with high caffeine intakes had significantly higher rates of bone loss at the spine than did those with low intakes. Investigators reported that women with the tt genetic variant of VDR (as opposed to the TT genotype) had significantly higher rates of bone loss at the spine when their caffeine intake was more than 300 milligrams (18 ounces of brewed coffee per day. Source: Rapuri
PB, Gallagher JC, Kinyamu HK, Ryschon KL. Caffeine intake increases the
rate of bone loss in elderly women and interacts with vitamin D receptor
genotypes. Am J Clin Nutr 2001;74(5):694-700.
|
||||||||||||||||||||||||||||||||||||
|
|
|
|
|
PO Box 39385 Fort Lauderdale, FL 33339-9385 USA |
|
Any use of the information presented herein is done strictly at your own risk. No responsibility is implied or intended on the part of HIV ReSources Inc, the editor, or the publisher. Information on this site should not be construed as an endorsement of any kind. |
|
|